Enanta Pharmaceuticals
ENTA | NASDAQ
$10.67
-$0.32 (-2.91%)
At close: Nov 16, 2026, 4:00 PM ET
$10.99
+$0.32 (+3.00%)
After-hours:
Nov 16, 2026, 7:34 PM ET
-2.91%
(1D)No price chart data available for 1D timeframe.
Rating
43
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #446/1021 (Top 44%)
Key Statistics
Market Data
Market Cap $310.77M
1D Range
10.63 11.09
52W Range
10.08 16.85
Valuation (TTM)
PE -4.43
PB 3.07
EV/EBITDA -3.90
Valuation (NTM)
Forward PE N/A
Forward PEG 1.10
Price Target $20.00
Cash Flow
FCF Yield -11.9%
SBC Adj. FCF Yield -16.8%
SBC Impact -41.3%
Margins
Gross Margin 98.2%
Operating Margin -90.0%
FCF Margin -56.6%
Growth (CAGR)
Revenue 3Y | 5Y -6.8% |
-7.7%
Dil EPS 3Y | 5Y 37.4% |
18.2%
FCF 3Y | 5Y 52.6% |
22.6%
Returns
ROA -21.3%
ROE -61.8%
ROIC -23.8%
Financial Health
Net Cash
$189.51M
Current Ratio 3.76
Interest Coverage -4.55
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Enanta Pharmaceuticals, Inc. is a biotechnology firm dedicated to discovering and advancing small molecule therapies designed to combat a range of viral infections and various liver conditions. Its re...
Sector Healthcare
Industry Biotechnology
Employees 120
IPO Date Mar 21, 2013
Website www.enanta.com
Fiscal Year October - September
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 16, 2026
EPS
-$0.81
Miss -11.88%
YoY:
+6.90% REV
$12.86M
Miss -12.05%
YoY:
-14.98%Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$20.00
Upside
+87.44%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove ENTA